EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anabolic-androgenic steroid use disorder: case for recognition as a substance use disorder with specific diagnostic criteria

Morgan Scarth iD, Ingrid Amalia Havnes, Astrid Bjørnebekk

The British Journal of Psychiatry · 2026

DOI: 10.1192/bjp.2025.73 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The British Journal of Psychiatry, 2026. Verfasst von Morgan Scarth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Anabolic Androgenic Steroid Research Group, Section for Clinical Addiction Research, Division of Mental Health and Addiction, Oslo University Hospita…. Hauptthemen laut MEDLINE: Substance-Related Disorders, Anabolic Agents, Androgens, Testosterone Congeners. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately one in three people who use anabolic-androgenic steroids (AASs) develop dependence, characterised by both psychiatric and somatic symptoms. Despite this, AAS use disorder (AASUD) is not distinctly recognised in the latest versions of either the ICD or DSM, impeding both clinical care and research progress. It is clear that AASUD shares many features and correlates with substance use disorders (SUDs) that have specific diagnostic criteria in these classification systems, such as stimulants or opioids. We aim to outline the overlap between AASUD and more ‘typical’ SUDs as well as highlight the specific concerns related to AASUD that warrant recognition and distinct diagnostic criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersAnabolic AgentsAndrogensTestosterone CongenersHumans

Stichwörter der Autor:innen

Diagnosis and classificationanabolic-androgenic steroidsdependenceperformance-enhancing drugssubstance use disorders

Substanzen

Anabolic AgentsAndrogensTestosterone Congeners

Autor:innen und Institutionen

  • Anabolic Androgenic Steroid Research Group, Section for Clinical Addiction Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

ORCID-Profile: Morgan Scarth

Zitieren

APA

Scarth, M., Havnes, I. A., & Bjørnebekk, A. (2026). Anabolic-androgenic steroid use disorder: case for recognition as a substance use disorder with specific diagnostic criteria. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.2025.73

Vancouver

Scarth M, Havnes IA, Bjørnebekk A. Anabolic-androgenic steroid use disorder: case for recognition as a substance use disorder with specific diagnostic criteria. The British Journal of Psychiatry. 2026. doi:10.1192/bjp.2025.73

BibTeX
@article{Scarth2026,
  author = {Scarth, Morgan and Havnes, Ingrid Amalia and Bjørnebekk, Astrid},
  title = {Anabolic-androgenic steroid use disorder: case for recognition as a substance use disorder with specific diagnostic criteria},
  journal = {The British Journal of Psychiatry},
  year = {2026},
  doi = {10.1192/bjp.2025.73}
}
Kostenlos starten →